Rachel Eisen

Rachel Eisen

Associate
Northern Virginia

Email [email protected]​hoganlovells.com

Phone +1 703 610 6136

Fax +1 703 610 6200

LanguagesEnglish

Practice groupIntellectual Property, Media, and Technology

Rachel Eisen is a valuable resource for clients as they navigate a variety of complex commercial and cross-border transactions. Providing thoughtful solutions and skillful drafting, Rachel's focus is always to protect clients' interests and accomplish their objectives.

Rachel supports clients on a variety of commercial matters including R&D, manufacturing and supply chain, IT procurement/outsourcing, and licensing, commercialization, and protection of intellectual property assets. Rachel also works closely with her corporate colleagues to provide advice in connection with M&A, debt and equity financing, and PE and VC matters, with attention to technology, intellectual property, and other commercial issues. Rachel's work spans numerous industries including life sciences and health care, consumer products, hospitality, professional services, education, media and entertainment, telecom, and aerospace.

Prior to joining Hogan Lovells, Rachel earned her J.D. at the George Washington University Law School, where she was a member of the George Washington International Law Review. Rachel also holds a Bachelor of Science in Management and Marketing with a minor in Global Studies, focusing on international business and globalization, from the University of Illinois. 

Rachel makes it a priority to use her skills to the benefit of her community, which she does through pro bono work and volunteering. Rachel is particularly interested in assisting small businesses and social enterprises in meeting the needs of underserved communities.

Education and admissions

Education

J.D., The George Washington University Law School, 2017

B.S., University of Illinois, 2013

Bar admissions and qualifications

Virginia

Representative experience

Ongoing representation of food and beverage manufacturers and retailers in commercial matters.

Ongoing representation of laboratory services providers in commercial matters, including consumer genetic testing.

Advising 21st Century Fox in its US$910m acquisition of seven broadcast television stations from Sinclair Broadcast Group and Tribune Media Company.

Advising pSivida on its acquisition of Icon Bioscience and rebranding as EyePoint Pharmaceuticals.

Advising Marvell Technology Group on its US$6bn acquisition of Cavium.

Advised DLH Holdings, a health care services contractor, on its US$70m acquisition of Social & Scientific Systems, a public health research organization.

Loading data